-
Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247 | Morningstar
来源: Buzz FX / 18 9月 2024 07:34:14 America/Chicago
[Business Wire](/news/business-wire) Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247 Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247 - The first healthy volunteer has
Read more...